Inventor · disambiguated record
John L. Gilmore
Also filed as: GILMORE JOHN · GILMORE JOHN L · GILMORE JOHN LODGE
31 granted patents·2 pending applications·211 citations·filing 1995–2022
95Inventor score
Top patents by PatentIndex Score
33 records- 0195US11053244B14-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 6, 2021·6 cites·7 claims
- 0293US10730877B24-Azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 4, 2020·6 cites·13 claims
- 0392US5919790AHydroxamate inhibitors of interleukin-1β converting enzymeWARNER LAMBERT CO·Filed 1997·Granted Jul 6, 1999·60 cites·16 claims
- 0485US11447466B2Substituted indole compounds useful as inhibitors of TLR7/8/9BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 20, 2022·3 cites·7 claims
- 0584US7253283B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 7, 2007·6 cites·15 claims
- 0684US6001331AMethod of imaging amyloid depositsWARNER LAMBERT CO·Filed 1997·Granted Dec 14, 1999·76 cites·17 claims
- 0783US8399451B2Heterocyclic compoundsGILMORE JOHN L·Filed 2010·Granted Mar 19, 2013·12 cites·11 claims
- 0882US10166249B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·2 cites·7 claims
- 0981US9522888B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 20, 2016·2 cites·12 claims
- 1078US11701373B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 18, 2023·0 cites·5 claims
- 1176US11597721B2Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 7, 2023·1 cites·11 claims
- 1276US7211671B2Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 1, 2007·15 cites·12 claims
- 1375US11058696B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 13, 2021·0 cites·4 claims
- 1473US11820768B24-azaindole compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 21, 2023·0 cites·10 claims
- 1573US7074810B2Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzymeBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 11, 2006·6 cites·23 claims
- 1672US10709719B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 14, 2020·0 cites·10 claims
- 1770US8067447B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofSHEPPECK JAMES E·Filed 2007·Granted Nov 29, 2011·2 cites·12 claims
- 1868US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 1967US5652237A2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processesWARNER LAMBERT CO·Filed 1995·Granted Jul 29, 1997·14 cites·20 claims
- 2061US9770459B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 26, 2017·0 cites·17 claims
- 2156US7544808B2Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 9, 2009·0 cites·14 claims
- 2255US11998537B2Substituted indole dimer compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 4, 2024·0 cites·8 claims
- 2355US11046646B2Alkylphenyl compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 29, 2021·0 cites·14 claims
- 2452US12172995B2Substituted indole and indazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 24, 2024·0 cites·9 claims
- 2552US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 2651US12240840B2Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alphaBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·2 claims
- 2747US2023150979A1Amide-disubstituted pyridine or pyridazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2846US11878975B2Substituted indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 23, 2024·0 cites·14 claims
- 2945US7625921B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 1, 2009·0 cites·14 claims
- 3045US7605264B2Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 20, 2009·0 cites·15 claims
- 3145US7569689B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 4, 2009·0 cites·15 claims
- 3244US8198311B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofSHEPPECK JAMES E·Filed 2007·Granted Jun 12, 2012·0 cites·9 claims
- 3343US7361654B2Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 22, 2008·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when John L. Gilmore files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →